Summary:
A phase 2 study to evaluate the safety and Efficacy of 6 and 12 mg of Proellex administered orally in the treatment of Premenopausal Women with confirmed Symptomatic Endometriosis.
Qualified Participants Must:
• Be female
•
Be between 18 and 47 years of age
Qualified Participants May Receive:
Study participants will receive all study related care and study medication at no cost, plus compensation for time and travel.